Top-News
Biotechnologie Großbritannien

Adaptimmune Therapeutics plc ADR

Aktie
WKN:  A14SUX ISIN:  US00653A1079 US-Symbol:  ADAP
0,2789 $
+0,0038 $
+1,38%
0,2463 € 17:09:14 Uhr
Depot/Watchlist
Aktienanzahl *
227,12 Mio.
Marktkapitalisierung *
56,07 Mio. €
Streubesitz
50,14%
Faktor
6
Originalaktie
GB00BVYV1687
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 22.11.2024

Adaptimmune Therapeutics plc ADR News

08.02.25 - Boersia.de
Adaptimmune Therapeutics Aktie: Ein Lichtblick für die Branche
Die Biotechnologie-​Aktie Adaptimmune Therapeutics zeigt weiterhin eine positive Entwicklung an den Börsen. Der Aktienkurs des biopharmazeutischen Unternehmens stieg am 8. ...
14.12.24 - Börse-Global
Adaptimmune Therapeutics Aktie: Anleger in Alarmbereitschaft
Die Biotechnologie-​Aktie Adaptimmune Therapeutics verzeichnet aktuell eine herausfordernde Phase an den Börsen. Der Aktienkurs fiel am 14. Dezember 2024 auf 0,5801 USD, ...
23.10.24 - Boersia.de
Adaptimmune Therapeutics Aktie: Kursrückgang trotz positiver Jahresentwicklung
Die Adaptimmune Therapeutics Aktie verzeichnete gestern einen leichten Rückgang von 1,68% und schloss bei 0,81 USD. Trotz des jüngsten Kursrückgangs zeigt die Aktie eine ...
11.04.23 - PR Newswire
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ROCC, KBAL, ADAP, TCRR
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ROCC, KBAL, ADAP, TCRR PR Newswire
06.04.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RADI, ADAP, TCRR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RADI, ADAP, TCRR PR Newswire
28.03.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, RADI, ADAP, TCRR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, RADI, ADAP, TCRR PR Newswire
23.03.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSEY, ADAP, TCRR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSEY, ADAP, TCRR PR Newswire
07.03.23 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLC Investigates RADI, ADAP, TCRR, ROCC
INVESTIGATION ALERT: Halper Sadeh LLC Investigates RADI, ADAP, TCRR, ROCC PR Newswire
14.03.22 - PR Newswire
Thinking about buying stock in Turquoise Hill Resources, Mullen Automotive, Frontier Group, Adaptimmune Therapeutics, or Nokia?
Thinking about buying stock in Turquoise Hill Resources, Mullen Automotive, Frontier Group, Adaptimmune Therapeutics, or Nokia? PR Newswire
15.09.21 - PR Newswire
Thinking about buying stock in Microvast, FuelCell Energy, Workhorse Group, Adaptimmune Therapeutics, or American Resources?
Thinking about buying stock in Microvast, FuelCell Energy, Workhorse Group, Adaptimmune Therapeutics, or American Resources? PR Newswire
13.09.21 - PR Newswire
Thinking about buying stock in Leap Therapeutics, Aterian, Hepion Pharmaceuticals, Adaptimmune Therapeutics, or Endo International?
Thinking about buying stock in Leap Therapeutics, Aterian, Hepion Pharmaceuticals, Adaptimmune Therapeutics, or Endo International? PR Newswire
07.09.21 - PR Newswire
Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics?
Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics? PR Newswire
20.05.21 - PR Newswire
Thinking about buying stock in Oncternal Therapeutics, Polarityte, Adaptimmune Therapeutics, Oncolytics Biotech, or Precipio?
Thinking about buying stock in Oncternal Therapeutics, Polarityte, Adaptimmune Therapeutics, Oncolytics Biotech, or Precipio? PR Newswire
02.06.20 - PR Newswire
Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis?
Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis? PR Newswire
12.05.20 - PR Newswire
Thinking about buying stock in Adaptimmune Therapeutics, Upwork, Eldorado Resorts, Co-Diagnostics, or Delta Air Lines?
Thinking about buying stock in Adaptimmune Therapeutics, Upwork, Eldorado Resorts, Co-​Diagnostics, or Delta Air Lines? PR Newswire
08.01.18 - GlobeNewswire
Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company
Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company Successful Manufacturing of SPEAR T-...
06.11.17 - GlobeNewswire
Adaptimmune marks Official Opening of U.K. Headquarters
Adaptimmune marks Official Opening of U.K. Headquarters Flagship Facility is new Base for U.K. Research and Development Operations PHILADELPHIA and OXFORD, U.K., Nov. ...
07.09.17 - GlobeNewswire
GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO
GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO PHILADELPHIA and OXFORD, United Kingdom, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Adaptimmune ...
27.03.17 - GlobeNewswire
Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional American Depositary Shares
Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional American Depositary Shares PHILADELPHIA and ...
22.03.17 - GlobeNewswire
Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares
Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares PHILADELPHIA and OXFORD, United Kingdom, March 22, 2017 (GLOBE NEWSWIRE) -- ...

Newssuche

Videos

newspaper
30.04.25 +13,48%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »